Pre-clinical Models of Pancreatic Ductal Adenocarcinoma

Hwang, C. I., Boj, S. F., Clevers, H., Tuveson, D. A. (January 2016) Pre-clinical Models of Pancreatic Ductal Adenocarcinoma. J Pathol, 238 (2). pp. 197-204. ISSN 1096-9896 (Electronic)0022-3417 (Linking)

DOI: 10.1002/path.4651


Pancreatic ductal adenocarcinoma (PDA) is one of the most difficult human malignancies to treat. Five-year survival rate of PDA patients is 7%, and PDA is predicted to become the second leading cancer-related cause of death in the United States of America. Despite intensive efforts, the translation of findings in preclinical studies has been ineffective, due partially to the lack of preclinical models that faithfully recapitulate features of human PDA. Here we review current preclinical models for human PDA (e.g. human PDA cell lines, cell line-based xenografts and patient-derived tumor xenografts). In addition, we discuss potential applications of the recently developed pancreatic ductal organoids, three-dimensional culture systems and organoid-based xenografts as new preclinical models for PDA.

Item Type: Paper
Uncontrolled Keywords: Pancreatic cancer organoid patient-derived tumor xenograft preclinical model
Subjects: organism description > model organism
diseases & disorders > cancer > cancer types > pancreatic cancer
CSHL Authors:
Communities: CSHL Cancer Center Program > Signal Transduction
CSHL labs > Tuveson lab
CSHL Cancer Center Program > Cellular Communication in Cancer Program
Depositing User: Matt Covey
Date: January 2016
Date Deposited: 01 Oct 2015 21:37
Last Modified: 22 Oct 2020 21:07
PMCID: PMC4700534
Related URLs:

Actions (login required)

Administrator's edit/view item Administrator's edit/view item
CSHL HomeAbout CSHLResearchEducationNews & FeaturesCampus & Public EventsCareersGiving